Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Assets (2022 - 2025)

Historic Assets for Immunocore Holdings (IMCR) over the last 4 years, with Q3 2025 value amounting to $1.1 billion.

  • Immunocore Holdings' Assets rose 164.68% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 164.68%. This contributed to the annual value of $1.0 billion for FY2024, which is 6909.62% up from last year.
  • According to the latest figures from Q3 2025, Immunocore Holdings' Assets is $1.1 billion, which was up 164.68% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Assets ranged from a high of $1.1 billion in Q3 2025 and a low of $526.8 million during Q4 2022
  • For the 4-year period, Immunocore Holdings' Assets averaged around $938.7 million, with its median value being $1.0 billion (2024).
  • As far as peak fluctuations go, Immunocore Holdings' Assets soared by 6909.62% in 2024, and later surged by 164.68% in 2025.
  • Quarter analysis of 4 years shows Immunocore Holdings' Assets stood at $526.8 million in 2022, then grew by 13.33% to $597.0 million in 2023, then surged by 69.1% to $1.0 billion in 2024, then increased by 9.21% to $1.1 billion in 2025.
  • Its Assets stands at $1.1 billion for Q3 2025, versus $1.1 billion for Q2 2025 and $1.0 billion for Q1 2025.